Satellite symposia

Satellite symposia are organised by pharmaceutical companies. These symposia are open to all congress participants. Responsibility for the programme content remains by the sponsor.

 ECCO has scheduled parallel satellite symposia on the following days:

  • Thursday, March 7, 2018 at 11:00-12:00 and 18:45-19:45
  • Friday, March 8, 2018 at 07:15-08:15 and  18:35-19:35

Educational lunchtime satellite symposia are scheduled for:

  • Friday, March 8, 2018 at 12:40-13:20

Satellite symposia are held in the Plenary hall (Halle A), C1 M4-5 (Halle C), Auditorium 15 (Congress Centre) and C1 M1 (Hall C), all on the ground floor.

The programmes of satellite symposia are not affiliated with ECCO.

 

  • Takeda

    Satellite symposium 1a: Takeda
    Plenary Hall, Hall A, Bella Center


    11:00-12:00 Treatment decisions with advanced therapies: Comparative evidence in Ulcerative Colitis
    Invitation to Satellite Symposium
    Jean-Frédéric Colombel, New York, United States
    11:00-11:10 Introduction: Comparing therapies to facilitate therapeutic decision-making
    Jean-Frédéric Colombel, New York, United States
    11:10-11:25 Key learnings from indirect comparisons of randomised controlled trials 
    William J. Sandborn, La Jolla, United States
    11:25-11:40 What do real-world comparative effectiveness studies tell us?
    Parambir Dulai, La Jolla, United States
    11:40-11:55 Our evolving understanding of gut-selective vs advanced systemic therapy
    Jean-Frédéric Colombel, New York, United States
    11:55-12:00 Q&A and Discussion
    All

    Satellite symposium 1b: AbbVie
    Hall C, C1 M4-5, Bella Center

    AbbVie

    11:00- 12:00 Future targets and endpoints in IBD – an informed discussion
    Invitation to Satellite Symposium
    Brian Feagan, London, Canada
    11:00-11:05 Welcome and Introduction
    Brian Feagan, London, Canada
    11:05-11:25 Evolving endpoints in clinical trials
    Brian Feagan, London, Canada
    11:25-11:40 Exploring the value of biomarkers and endoscopic targets
    Peter Bossuyt, Bonheiden, Belgium
    11:40-11:55 Interpreting patient-reported outcomes
    Reena Khanna, London, Canada
    11:55-12:00 Conclusing remarks and close
    Brian Feagan, London, Canada


    Satellite symposium 1c: Celltrion
    Auditorium 15, Bella Center

    Celltrionhealthcare TM Updated Symposium 2016

    11:00- 12:00 Redesigning the Future of IBD Treatment with Infliximab SC
    Invitation to Satellite Symposium
    Walter Reinisch, Vienna, Austria
    11:00-11:05 Welcome remarks
    Walter Reinisch, Vienna, Austria
    11:05-11:15 Personalised Anti-TNF therapy in Crohn’s Disease (PANTS)
    Tariq Ahmad, Exeter, United Kingdom
    11:15-12:25 Clinical findings on Infliximab SC
    Shomron Ben-Horin, Ramat Gan, Israel
    11:25-11:35 Earlier introduction of biologics
    Iris Dotan, Petah Tikva, Israel
    11:35-11:45 Future of IBD treatment with Infliximab SC
    Stefan Schreiber, Kiel, Germany
    11:45-12:00 Panel discussion
    All


    N-ECCO Network Meeting: Takeda
    Hall C, C1 M0, Bella Center

    Takeda



    12:15- 13:15 Bon voyage! Preparing our patients for confident travel with IBD
    Invitation to Satellite Symposium

    Stepping out of your comfort zone: You can travel with IBD!
    Video from Hannah Witton (Vlogger with IBD)
    Welcome and introductions 
    Stephan Vavricka, Zurich, Switzerland 
      Travelling with IBD, from research to reality
    Stephan Vavricka, Zurich, Switzerland 
      How to advise patients: Practical tips to help travellers with IBD
    Shomron Ben-Horin, Ramat Gan, Israel
    Kay Greveson, London, United Kingdom
      Q&A
    Moderator: Stephan Vavricka, Zurich, Switzerland 
    All
      Summary of key learning points
    Shomron Ben-Horin, Ramat Gan, Israel


    S-ECCO IBD Masterclass: Takeda
    Hall C, C1 M2, Bella Center

    Takeda



    12:15- 13:15 The future is now: Improved management of complex perianal fistulas in Crohn’s disease
    Invitation to Satellite Symposium

    Welcome and speaker introductions
    Antonino Spinelli, Milan, Italy
    Discussion and introduction to the cases: Goal-setting in complex perianal fistula 
    Antonino Spinelli, Milan, Italy
    Henit Yanai, Petah Tikva, Israel
      Matching the patient to the procedure choice for complex perianal fistula
    Antonino Spinelli, Milan, Italy
      Optimising long-term strategies for complex perianal fistula in Crohn’s disease
    Henit Yanai, Petah Tikva, Israel
      Discussion and key learnings
    Antonino Spinelli, Milan, Italy
    Henit Yanai, Petah Tikva, Israel


    Satellite symposium 2a: Pfizer
    Plenary Hall, Hall A, Bella Center

    Pfizer

    18:45- 19:45 Tofacitinib in Ulcerative Colitis: A practical guide
    Invitation to Satellite Symposium
    Simon Travis, Oxford, United Kingdom
    18:45-18:50 Welcome and Introduction
    Simon Travis, Oxford, United Kingdom
    18:50-19:05 Tofacitinib: An effective option for moderate-to-severe Ulcerative Colitis
    Simon Travis, Oxford, United Kingdom
    19:05-19:20 Exploring the Tofacitinib safety profile
    Axel Dignass, Frankfurt, Germany
    19:20-19:40 The practicalities of using Tofacitinib in the clinic
    Peter Irving, London, United Kingdom
    19:40-19:45 Q&A
    All

    Satellite symposium 2b: Amgen
    Hall C, C1 M4-5, Bella Center

    Amgen Biosimilars logo 4C

    18:45- 19:45 The IBD management puzzle: Do we have all the pieces?
    Invitation to Satellite Symposium
    Stefan Schreiber, Kiel, Germany
    18:45-18:50 Welcome
    Stefan Schreiber, Kiel, Germany
    18:50-19:05 Putting the pieces together: When should Anti-TNFs be introduced?
    Followed by interactive Q&A
    Stefan Schreiber, Kiel, Germany

    19:05-19:20 Solving the riddle: How do we implement TDM to maximise treatment success?
    Followed by interactive Q&A
    Walter Reinisch, Vienna, Austria

    19:20-19:35 Unravelling the problem: How can biomarkers be used to guide clinical management?
    Followed by interactive Q&A
    Gionata Fiorino, Milan, Italy

    19:35-19:45 Summary and close
    Stefan Schreiber, Kiel, Germany

    Satellite symposium 2c: Janssen
    Auditorium 15, Bella Center

    Janssen



    18:45- 19:45 IL-12/23 in IBD: Making the best use of available evidence
    Invitation to Satellite Symposium
    Alessandro Armuzzi, Rome, Italy
    18:45-18:50 Welcome and Introduction
    Alessandro Armuzzi, Rome, Italy
    18:50-19:00 Current developments in IBD
    Subrata Gosh, Birmingham, United Kingdom
    19:00-19:30 Clinical insights in IBD
    Moderator: Tim Raine, Cambridge, United Kingdom
    Speakers: Alessandro Armuzzi, Rome, Italy
    Subrata Gosh, Birmingham, United Kingdom
    19:30-19:35 Future treatment options in IBD
    Alessandro Armuzzi, Rome, Italy
    19:35-19:45 Conclusion and close of meeting
    Tim Raine, Cambridge, United Kingdom
  • Satellite symposium 3b: Nestle Health Science
    Hall C, C1 M4-5, Bella Center                                

    NHSc logotype 2017

    07:15-08:15 Why do we need dietary therapy in Crohn’s disease?
    Invitation to Satellite Symposium
    Iris Dotan, Petah Tikva, Israel
    Michael Kamm, Melbourne, Australia
    07:15-07:30 Why do we need nutrition therapy in an era of biologics?
    Michael Kamm, Melbourne, Australia
    07:30-07:45 What are the targets for dietary therapy?
    Arie Levine, Tel Aviv, Israel
    07:45-08:00 Present state of the art on dietary management in Crohn’s Disease
    Johan van Limbergen, Halifax, Canada & Amsterdam, The Netherlands 
    08:00-08:15 The new kid on the block: The Crohn’s Disease Exclusion Diet for induction of remission
    Rotem Sigall-Boneh, Tel Aviv, Israel

    Satellite symposium 3c: Pfizer
    Auditorium 15, Bella Center

    Pfizer


    07:15-08:15 The Psychology of Change in IBD: Working with the mind when the gut needs a change
    Invitation to Satellite Symposium
    David Rubin, Chicago, Unites States
    07:15-07:20 Welcome and Introduction
    David Rubin, Chicago, Unites States
    07:20-07:35 Understanding the psychological drivers of decision making in IBD 
    Lyndsay Hughes, London, United Kingdom
    07:35-07:50 The psychology of IBD management: Challenging ourselves to change
    David Rubin, Chicago, Unites States
    07:50-08:05 Preparing our patients when the gut needs a change
    Tariq Ahmad, Exeter, United Kingdom
    08:05-08:15 Q&A

    Satellite symposium LS1: AbbVie
    Plenary Hall, Hall A, Bella Center

    AbbVie


    12:40-13:20 Rapid control of Ulcerative Colitis: Can we optimise treatment?
    Invitation to Satellite Symposium
    Jean-Frédéric Colombel, New York, United States
    12:40-12:45 Welcome and Introduction
    Jean-Frédéric Colombel, New York, United States
    12:45-12:55 Understanding the inflammatory and symptomatic picture of Ulcerative Colitis
    Johan Burisch, Copenhagen, Denmark
    12:55-13:05 Timely management of Ulcerative Colitis
    Jean-Frédéric Colombel, New York, United States
    13:05-13:15 Optimising therapy – Approaches to enhance clinical outcomes
    Edouard Louis, Liège, Belgium
    13:15-13:20 Concluding remarks and close
    Jean-Frédéric Colombel, New York, United States

    Satellite symposium LS2: Celgene
    Hall C, C1 M4-5, Bella Center     

    Celgene logo

    12:40-13:20 How will evolving therapies illuminate your practice?
    Invitation to Satellite Symposium
    12:40-13:20 How will evolving therapies illuminate your practice?
    Remo Panaccione, Calgary, Canada
    Jonas Halfvarson, Örebro, Sweden

    Satellite symposium LS3: Tillotts
    Auditorium 15, Bella Center         

    1 2 logo tillotts
       

    12:40-13:20 Smart Simplicity - Simplifying treatment options and processes
    Invitation to Satellite Symposium
    Geert D’Haens, Amsterdam, The Netherlands
     12:40-12:45 Welcome and Introduction
    Geert D’Haens, Amsterdam, The Netherlands
    12:45-13:00 Difference between textbook and reality in IBD
    Ala Sharara, Beirut, Lebanon
    13:00-13:15 Confusing terminology in IBD
    Hugh Mulcahy, Dublin, Ireland
    13:15-13:20 Closing remarks
    All

    Satellite symposium LS4: MSD
    Hall C, C1 M1, Bella Center          

    1 2 logo msd
       
    12:40-13:20 Treat-to-Target in Ulcerative Colitis: Challenges in real-life practice
    Invitation to Satellite Symposium
    Glen Doherty, Dublin, Ireland
    12:40-12:55 Targets and outcome measures in Ulcerative Colitis: IOIBD consensus vs real-life practice
    Alexander Moschen, Innsbruck, Austria
    12:55-13:10 Effective early control of inflammation in patients with active Ulcerative Colitis
    Glen Doherty, Dublin, Ireland
    13:10-13:15 Summary and Q&A
    All

    Satellite Symposium 4a: Takeda
    Plenary Hall, Hall A, Bella Center

    Takeda


    18:35-19:35 Evolving models of care in Crohn’s disease: Identifying and treating patients at risk of disease progression
    Invitation to Satellite Symposium
    Remo Panaccione, Calgary, Canada
    18:35-18:40 Introduction
    Remo Panaccione, Calgary, Canada
    18:40-18:55 Early disease control: Identifying patients at risk of disease progression
    Edouard Louis, Liege, Belgium
    18:55-19:15 Practical approaches for the management of Crohn’s disease according to risk stratification
    Remo Panaccione, Calgary, Canada
    19:15-19:35 Challenging patient cases: Low risk or high risk – what would you do?
    Subrata Gosh, Birmingham, United Kingdom

    Satellite symposium 4c: Biogen and Samsung Bioepis
    Auditorium 15, Bella Center

    BIO61045 Biogen Samsung RGB Lockup HORIZONTAL

    18:35-19:35 The IBD pathway – from a patient perspective
    Invitation to Satellite Symposium
    Geert D’Haens, Amsterdam, The Netherlands
    18:35-18:45 Welcome and Introduction
    Geert D’Haens, Amsterdam, The Netherlands
    18:45-19:30 Patient perspectives, such as their expectations and concerns as they experience a switch in treatment will be discussed with the audience by a multidisciplinary team:
    Raja Atreya, Nürnberg, Germany
    Luisa Avedano (EFCCA), Brussels, Belgium
    Yoram Bouhnik, Paris, France
    Maria de Jong, Amsterdam, The Netherlands

    Geert D’Haens, Amsterdam, The Netherlands
    19:30-19:35 Closing remarks
    Geert D’Haens, Amsterdam, The Netherlands

    Satellite symposium 4d: Sandoz
    Hall C, C1 M1, Bella Center

    sandoz nov div logo pos rgb

    18:35-19:35 Defining the future of IBD care: The pivotal role of personalised treatment
    Invitation to Satellite Symposium
    Peter Irving, London, United Kingdom
    18:35-18:40 The myth of the typical IBD patient (introduction)
    Peter Irving, London, United Kingdom
    18:40-19:00 IBD subgroups: The secret of hitting the mark
    Chair: Peter Irving, London, United Kingdom
    Speaker: Marieke Pierik, Maastricht, The Netherlands
    Jonas Halfvarson, Örebro, Sweden
    19:00-19:15 Hidden gems of rheumatology
    Frank Behrens, Frankfurt, Germany
    19:15-19:30 Personalised treatment for IBD: Of course, but why and how?
    Claudio Fiocchi, Cleveland, United States
    19:30-19:35 Closing remarks
    Peter Irving, London, United Kingdom